KRAS and cancer: Our data revealed that, in contrast to what has previously been described regarding the capacity of mutKRAS cancer cells to modulate the tumor immune microenvironment, the pro-tumorigenic features of fibroblasts are mainly regulated by CRC cells independently of oncogenic KRAS.